Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Combining DEB-BACE with chemotherapy is more effective and has fewer side effects than chemotherapy alone for treating unresectable lung squamous cell carcinoma.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

Many treatments for alopecia areata have inconsistent results; for under 10s, use minoxidil with a corticosteroid, and for over 10s, add ILC and consider diphenylcyclopropenone for widespread cases.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

IL-17C is important in inflammatory skin diseases and could be a target for treatment.

Daylight photodynamic therapy is effective and well-tolerated for treating actinic keratoses with minimal side effects.

Abrocitinib effectively treats severe alopecia areata with significant improvement and no side effects.

Dupilumab may help treat alopecia areata without needing high IgE levels.

Some JAK inhibitors are effective for significant hair regrowth in alopecia areata.

Ritlecitinib is generally safe for long-term use in treating alopecia areata.

Oral Janus kinase inhibitors are effective for treating alopecia areata in adults.

JAK inhibitors help regrow hair in alopecia areata patients, improving their quality of life.

JAK inhibitors effectively treat severe alopecia areata with manageable side effects.

Dupilumab may help treat hair loss and skin color loss in some patients with atopic dermatitis.

Systemic corticosteroids might help treat hair loss caused by alemtuzumab in MS patients.

Patients with alopecia areata prefer treatments that regrow scalp hair quickly over how often they need to take the medication.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

Dupilumab can help regrow hair and improve skin conditions in patients with severe atopic dermatitis and alopecia areata.

Tralokinumab may help improve symptoms of atopic dermatitis and alopecia areata.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

JAK inhibitors do not increase cancer risk in severe alopecia areata compared to traditional treatments.

IL-15 helps protect hair follicles from immune attacks and encourages hair growth.

Dupilumab helps children with alopecia areata regrow hair safely.

Upadacitinib and narrowband UVB effectively treated a child's vitiligo and alopecia areata.

Anifrolumab improves quality of life and reduces steroid use in lupus patients.

BD 1/4 dilution is the best for treating localized alopecia areata in adults.

Allergies, especially dust mite allergy, may worsen alopecia areata, and desensitization could help reduce its severity.

The new therapy using specific stem cells from umbilical cords speeds up healing of chronic skin wounds.